Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02664324 · ClinicalTrials.gov registry record

MSPT Device Usability Study

A clinical trial of Multiple Sclerosis, sponsored by Biogen.

Completed
Registry status
60
Enrollment target
3
Study locations

NCT02664324 is a study of Multiple Sclerosis that has completed, run by Biogen. The registered enrollment target is 60 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02664324, a study of Multiple Sclerosis, has completed, sponsored by Biogen.

COMPLETED
Registry status
60 participants
Enrollment target
3
Study locations

Study Summary

The primary objective of this feasibility study is to evaluate the functionality (e.g., as defined by the primary endpoints) of the fully integrated Multiple Sclerosis Performance Test (MSPT) device, when used by unsupervised participants with MS, or related conditions, with a broad range of disability, in multi-clinical-care environments. Secondary objectives include: Participant perception of usability of device; Participant satisfaction with the device; Ascertain the impact of different clinical environments on device usability; Ascertain impact of assistive devices in usability of device; Ascertain functionality of Bluetooth remote as compared with manual timing.

Conditions Studied

Multiple Sclerosis

Study Locations (3)

Maryland

  • Research Site - Baltimore

New York

  • Research Site - New York

Ohio

  • Research Site - Cleveland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-03
Est. Completion 2016-04

Sponsor

Biogen

334 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02664324

The ClinicalTrials.gov registry entry for NCT02664324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT02664324 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT02664324 about?

NCT02664324 is a clinical study titled "MSPT Device Usability Study". The primary objective of this feasibility study is to evaluate the functionality (e.g., as defined by the primary endpoints) of the fully integrated Multiple Sclerosis Performance Test (MSPT) device, when used by unsupervised participants with MS, or related conditions, with a broad range of disabil...

What is the current status of trial NCT02664324?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-03. Estimated completion is 2016-04.

What conditions does trial NCT02664324 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT02664324?

This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02664324 being conducted?

This trial has 3 study locations across Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.